A gene on the X chromosome revs up inflammation in the female brain, which may explain why rates of multiple sclerosis are ...

A biology teacher and mother-of-two has become the first UK patient to receive a "gamechanger" therapy to treat multiple ...

Doctors are looking to recruit more people for the trial, which they say could one day be given as a single one-off treatment ...

Enrollment is complete for the randomized part of ENHANCE, a Phase 3 trial testing a new dosing schedule for Briumvi in ...

Learn about multiple sclerosis, its symptoms, causes, and treatment options. Understand how early diagnosis helps in managing ...

The price of Rebif has increased four times faster than the rate of inflation, with Kay's insurer deciding to stop covering ...

An event like this takes significant planning, teamwork, and collaboration to provide a safe and successful ride. The ...

A multiple sclerosis (MS) patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a ...

Because of how unpredictable MS symptom flares can be, columnist Desiree Lama often finds herself living a sheltered life.

TG Therapeutics (($TGTX)) announced an update on their ongoing clinical study. Study Overview: TG Therapeutics is conducting a Phase 3 study ...

A biology teacher has become the first patient in the UK to receive “gamechanger” therapy to treat multiple sclerosis.

Obexelimab met primary endpoint with a 95% relative reduction in new gadolinium (Gd)-enhancing T1 lesions compared with placebo, p=0.0009 ...